Evidence map›Paper›PMID 40871550›Full record

ArticleMolecules (Basel, Switzerland)2025

Targeted LC-MS Orbitrap Method for the Analysis of Azaarenes, and Nitrated and Oxygenated PAHs in Road Paving Emissions.

Maria Bou Saad, Sylvain Ravier, Amandine Durand, Brice Temime-Roussel, Vincent Gaudefroy, Audrey Pevere, Henri Wortham, Pierre Doumenq

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria Bou SaadLCE, Aix Marseille University, 13331 Marseille, France.ORCID 0009-0004-9494-9686
Sylvain RavierLCE, Aix Marseille University, 13331 Marseille, France.ORCID 0000-0002-2627-3360
Amandine DurandLCE, Aix Marseille University, 13331 Marseille, France.ORCID 0000-0002-6740-1138
Brice Temime-RousselLCE, Aix Marseille University, 13331 Marseille, France.ORCID 0000-0001-9978-6135
Vincent GaudefroyMaterials for Transportation Infrastructures Laboratory (MIT), Materials and Structures Department (MAST), Université Gustave Eiffel, Allée des Ponts et Chaussées, CS4, 44344 Bouguenais, France.ORCID 0000-0003-3361-9451
Audrey PevereCerema, University Gustave Eiffel, UMR MCD, 13100 Aix-en-Provence, France.ORCID 0000-0002-8035-2019
Henri WorthamLCE, Aix Marseille University, 13331 Marseille, France.ORCID 0000-0002-7778-8188
Pierre DoumenqLCE, Aix Marseille University, 13331 Marseille, France.ORCID 0000-0002-5145-3750

Funding

Agence de la transition écologique 23ESD0059SUD PACA Region EJD n°2022_03237
6 · The paper itself

Abstract

Polycyclic aromatic hydrocarbon (PAH) derivatives, specifically azaarenes and nitrated and oxygenated PAHs, are emerging contaminants of concern due to their increased toxicity and persistence compared to the parent PAHs. Despite their toxicity, their simultaneous analysis in complex matrices, such as in fumes emitted from bituminous mixtures, remains challenging due to limitations of conventional analytical techniques. To address this, an advanced methodology was developed using Ultra-High-Performance Liquid Chromatography coupled with High-Resolution Mass Spectrometry (UHPLC-HRMS Orbitrap Eclipse) equipped with an APCI source for the simultaneous identification and quantification of 14 PAH derivatives. Chromatographic and ionization parameters were optimized to ensure maximum sensitivity and selectivity. Following ICH Q2(R2) guidelines, the method was validated, demonstrating excellent linearity (R

Indexed as

azaarenesLC-HRMSnitrated PAHoxygenated PAHPAH derivativestrace-level quantification

Identifiers

PMID40871550
PMCPMC12388843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.